Updated 05/02

• Strong demand for pricing, valuation, and model‑risk actuaries
• Disability and mental‑health claims volatility impacting reserves
• IFRS 17 refinement work continuing across life & health portfolios
• AXIS and Prophet modellers remain in short supply
• Leadership turnover increasing in group risk and protection

• IFRS 17: Ongoing assumption refinement and disclosure pressure
• Solvency II: Capital strain on morbidity and disability blocks
• FCA: Heightened scrutiny on model governance and customer fairness
• Consumer Duty: Product value and outcome monitoring intensifying

In supporting UK insurers and reinsurers in building actuarial and leadership teams across pricing, valuation, IFRS 17, disability, and risk. Through a retained, multi‑hire model, I deliver predictable cost, strategic partnership, and access to hard‑to‑reach actuarial talent.